Shefali Agarwal's most recent trade in Fate Therapeutics Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 51,800 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 51,800 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 38,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 19,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 937 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 11,893 | 11,893 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,650 | 10,490 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Sale of securities on an exchange or to another person at price $ 21.89 per share. | 07 Jun 2022 | 841 | 1,840 (0%) | 0% | 21.9 | 18,409 | Common Stock |
| Gritstone Bio Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 937 | 937 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,334 | 4,334 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,681 | 2,681 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) |